Navigation Links
Inverness Medical Innovations Announces Second Quarter 2008 Results
Date:7/29/2008

on expense of $55.0 million and $10.1 million in the second

quarter of 2008 and 2007 GAAP results, respectively, including $11.7

million and $3.3 million charged to cost of sales, $1.0 million and $0.7

million charged to research and development and $42.1 million and $6.0

million charged to selling, general and administrative, in the respective

quarters, with $0.2 million and $0.1 million charged through equity

earnings of unconsolidated entities, net of tax during the respective

quarters.

(c) Restructuring charges associated with the decision to close facilities

of $23.6 million and $0.4 million for the second quarter of 2008 and 2007

GAAP results, respectively. The $23.6 million charge for the three months

ended June 30, 2008 included $4.8 million charged to cost of sales, $3.2

million charged to research and development, $3.0 million charged to

selling, general and administrative, $6.6 million charged to interest

expense and $6.0 million charged through equity earnings of unconsolidated

entities, net of tax. The $0.4 million charge for the second quarter of

2007 was charged to selling, general and administrative. These charges

have been excluded from net income or loss because they have a significant

impact on results yet do not occur on a consistent or regular basis in the

Company's business.

(d) Compensation costs of $7.2 million and $47.3 million associated with

stock-based compensation expense for the second quarter of 2008 and 2007

GAAP results, respectively, including $0.4 million and $0.1 million

charged to cost of sales, $1.1 million and $0.5 million charged to

research and development and $5.7 million and $46.7 million charged to

selling, general and administrative, in the respective quarters. The

$46.7 million charged to selling, general and administrative during the

2007 quarter include
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Inverness Medical Innovations Agrees to Acquire Panbio Ltd.
2. Inverness - Chemogen Establish Exclusive License for TB Antibodies
3. Inverness Medical Innovations Announces Proposed Public Offering of Common Stock
4. Inverness Medical Innovations Agrees to Acquire ParadigmHealth
5. Inverness Medical Innovations Acquires ParadigmHealth
6. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
7. Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
8. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
9. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
10. Inverness Medical Innovations Announces Fourth Quarter 2007 Results
11. Inverness Medical Innovations to Participate at Bank of America 2008 Smid Cap Conference on March 26, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... supplement? InVitria has what scientists have been asking for! Zap-CHO ... the growth and productivity of CHO cells. Developed for scientists ... free, well defined and consistent recombinant CHO supplement. , ... ... 2009 -- Scientists working with CHO cells can now access ...
(Date:12/16/2009)... introduces HSP-A Soy Peptone. HSP A has been found to ... ... (PRWEB) December 16, 2009 -- Nu-Tek BioSciences, LLC. ( www.nu-tekproducts.com ... Soy Peptone. HSP-A, previously manufactured by Nutricepts, Inc. (Burnsville, Mn), ... improve growth rates and yields. HSP-A has been found to ...
(Date:12/15/2009)... Dec. 15 Epeius Biotechnologies Corporation, an ... medicine, gained international validation of the cutting-edge science ... when scientists around the world rediscovered the ... locus of cancer pathogenesis and disease progression, and ... scientists at the NIH National Cancer Institute investigating ...
(Date:12/15/2009)... Repligen Corporation (Nasdaq: RGEN ) today announced ... funding to support the ongoing development of new ... Association (MDA). This grant will support the ... manufacture of a drug candidate for human clinical ... provides important funding for Repligen,s research but it ...
Breaking Biology Technology:Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3
... German . , In this information age, ... and technology. A team of German and Italian researchers ... storage domains". As the scientists, led by Massimiliano Cavallini ... and Mario Ruben at the Forschungszentrum Karlsruhe (Germany), report ...
... Pa., Oct. 27 BioTrends Research Group, Inc.,released ... from 204 Nephrologists and 201 Renal Dietitians in ... of the management of dialysis,patients, particularly in their ... Vitamin D, and Calcimimetic agents., In the ...
... Jersey, October 27, Rosetta Genomics Ltd. (Nasdaq: ROSG ... and therapeutics, today,announced that Credit Suisse, as part ... Attorney General of the State of New York ... has begun to,repurchase Rosetta Genomics ARS. So far, ...
Other Biology Technology:Progress toward new storage media 2BioTrends Releases TreatmentTrends(TM): Nephrology and Renal Dietitians, Two Syndicated Reports Providing Continuing Insight into the Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases TreatmentTrends(TM): Nephrology and Renal Dietitians, Two Syndicated Reports Providing Continuing Insight into the Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3Credit Suisse Repurchases Auction Rate Securities (ARS) From Rosetta Genomics 2Credit Suisse Repurchases Auction Rate Securities (ARS) From Rosetta Genomics 3
(Date:12/15/2009)... The mouse is a standard laboratory model organism, ... conventional techniques to analyze blood and blood-forming tissues ... of compact and easy-to-use laboratory resources from Cold ... Mouse Hematology features step-by-step protocols for ... blood, bone marrow, and other hematopoietic tissues in ...
(Date:12/14/2009)... molecule in a freeze-tolerant Alaska beetle able to survive ... described biological antifreezes that contain protein, this new molecule, ... composed of a sugar and a fatty acid and ... organisms. , "The most exciting part of this ... kind of antifreeze that may work in a different ...
(Date:12/14/2009)... most comprehensive study to date of the proteins in ... provide important clues to how similar regeneration could be ... of Science at Indiana University-Purdue University Indianapolis and colleagues ... of axolotls, a type of salamander that has the ... of amputation, with the hope that this knowledge will ...
Breaking Biology News(10 mins):New source of classical techniques for blood-based studies in the laboratory mouse 2Scientists isolate new antifreeze molecule in Alaska beetle 2IUPUI researchers tackle protein mechanisms behind limb regeneration 2CPC Strengthens Foundation as a Closure Products Company with its Vertically Integrated Product Pipeline 48279 1CPC Strengthens Foundation as a Closure Products Company with its Vertically Integrated Product Pipeline 48279 2CPC Strengthens Foundation as a Closure Products Company with its Vertically Integrated Product Pipeline 48279 3CPC Strengthens Foundation as a Closure Products Company with its Vertically Integrated Product Pipeline 48279 4The Worlds Smallest Hero 21 Rexin G Targeted Therapy for Metastatic Cancers 12540 1The Worlds Smallest Hero 21 Rexin G Targeted Therapy for Metastatic Cancers 12540 2Computers Causing Injuries in the Home 48275 1Computers Causing Injuries in the Home 48275 2Computers Causing Injuries in the Home 48275 3
... created technology to regrow teeth--the first time scientists have ... low-intensity pulsed ultrasound (LIPUS), Dr. Tarak El-Bialy from the ... and Dr. Ying Tsui from the Faculty of Engineering ... and novel way to stimulate jaw growth and dental ...
... be blocked by pain medications such as Advil and ... understood, a Queen's University study has found. , "The ... we classify the commonly used anti-inflammatory and pain drugs ... professor of Biochemistry and Physiology at Queen's and Canada ...
... Noel Dahl and Mohammad F. Islam have made a ... disease that accelerates the aging process by about seven ... of chemical and biomedical engineering at Carnegie Mellon, said ... of the National Institutes of Health (NIH), the John ...
Other Biology News:Ultrasound may help regrow teeth 2New understanding of COX-1 and COX-2 enzymes could revise classification of pain meds 2Carnegie Mellon researchers discover new cell properties 2
... 48 lanes, 24 bi-directional, of patient DNA ... either slab gel or capillary sequencers, using ... parameters in Explorer have been sealed to ... have built Explorer for ease of use, ...
... Quality ISO 9001:2000 Certified USDA Research ... Validated, SOP's Training AALAS Certified ... All Procedures GLP Documentation Upon Request ... shopping point for all your custom immunology ...
...
Peptide-affinity Purified Polyclonal Antibody to Sphingolipid Receptor Edg8/S1P5...
Biology Products: